Data Driven Methods for Kinase Drug Design

webinar

Thu, 27 Apr 2023, 16:00 CEST (Berlin)

Prof. Dr. Andrea Volkamer, Saarland University, Germany

Data Driven Methods for Kinase Drug Design

Human protein kinases are involved in several diseases which turned them into an important class for targeted therapy. To date there are almost 6,000 kinase structures in the PDB and around 70 small molecule kinase inhibitors available. Still several challenges remain related to drug promiscuity, resistance, and untapped kinase territory.

In this BioSolveIT webinar, Andrea will summarize the portfolio of methods which either use the openly available kinase data to generate new knowledge, or enable the community to engage in this data more easily. Using the TeachOpenCADD platform, she will demonstrate how to orchestrate diverse CADD tasks for individual kinases. Furthermore, Andrea’s lab developed freely available tools supporting diverse tasks: (i) KinFragLib for fragment based kinase inhibitor design, (ii) KiSSim – a KLIFS-based kinase structural similarity fingerprint, and (iii) a pipeline to assess kinase similarity from different data perspectives. All examples make use of the OpenCADD-KLIFS module to facilitate the integration of KLIFS data into kinase research workflows.

Andrea will close with further ongoing projects in structure-informed ML for kinase polypharmacology (openkinome).

Join us for an exciting talk and a vivid discussion.

Current news

category
Events
Workshop: Next Generation of Compound Catalogs: Trillion-Sized eXplore Chemical Space @ San Diego
April 1, 2025 16:00 CEST
We are excited to announce a collaborative workshop between BioSolveIT and eMolecules, focusing on the Trillion-Sized eXplore Chemical Space. This hands-on session is designed for drug discovery enthusiasts eager to dive into the vast potential of ultra-large compound collections.​ Event Details: Date: Tuesday, April 15, 2025​ Time: 5:00 PM –...
Read on
Enamine’s REAL Space March 2025 Update - Now 76 Billion!
March 27, 2025 13:00 CET
The March 2025 update of Enamine’s REAL Space brings a new expansion — now featuring over 76 billion accessible, drug-like products, up from 70 billion in the previous release. With 172 curated reactions and 182,038 reagents and building blocks based on in-house knowledge, this version further enhances one of the...
Read on
CHEMriya Space Update: 55 Billion Molecules Unlocking New Frontiers in Drug Discovery!
March 13, 2025 14:00 CET
We are excited to announce a major update to OTAVA’s CHEMriya™ Chemical Space, now featuring 55 billion accessible molecules built upon 323 in-house reactions. With the March 2025 update, several new reactions have been added to the chemistry portfolio, expanding the space by over 43 billion novel molecules. This significant...
Read on